A PROSPECTIVE EVALUATION OF N-BUTYL CYANOACRYLATE FOR PERCUTANEOUS SCLEROTHERAPY OF SYMPTOMATIC SIMPLE RENAL CYST
• 2016
Publication Information
Authors
AMR EL-DAKHAKHNY, TAREK SOLIMAN, AHMED M. AL-ADL, TAREK EL-KARAMANY
Keywords
N-butyl cyanoacrylate, sclerotherapy, cystic kidney.
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Purpose: To assess the safety and efficacy of n-butyl cyanoacrylate (NBCA) and Iodized oil mixture as sclerotherapy for symptomatic simple renal cysts under ultrasound guidance.
Materials and Methods: This prospective study conducted between June 2013 and October 2015, included 33 patients (22 males and 11 females) with 41 symptomatic simple renal cysts (> 5 cm). The mean age + SD was 54.5 + 11.4 (range 41 to 76) years. Before procedure, cyst volume was evaluated by US and non-contrast enhanced CT. Percutaneous real-time aspiration and injection of mixture of NBCA and iodized oil under ultrasound guidance was done. After the procedure, patients were followed up from 3 to 12 months with periodic US examinations. Primary endpoint is complete collapse or decrease in cyst diameter > 50% and elimination of symptoms. Failure was defined as decreased cyst volume < 50% and/or persistence of symptoms.
Results: The mixture of NBCA and iodized oil was technically successful as sclerosing therapy for managing symptomatic simple renal cysts. During median follow up period of 6 months (range 3 to 12), complete disappearance was detected in 27/41 (65.9%), reduced diameter and dis-appearance of symptoms in 11/41 (26.8) and failed procedure (due to recurrence) was detected in 3/41 (7.3%). In all the cases with failure, the pre-procedure cyst diameter was ≥10 cm. After sclerotherapy, fever (
Materials and Methods: This prospective study conducted between June 2013 and October 2015, included 33 patients (22 males and 11 females) with 41 symptomatic simple renal cysts (> 5 cm). The mean age + SD was 54.5 + 11.4 (range 41 to 76) years. Before procedure, cyst volume was evaluated by US and non-contrast enhanced CT. Percutaneous real-time aspiration and injection of mixture of NBCA and iodized oil under ultrasound guidance was done. After the procedure, patients were followed up from 3 to 12 months with periodic US examinations. Primary endpoint is complete collapse or decrease in cyst diameter > 50% and elimination of symptoms. Failure was defined as decreased cyst volume < 50% and/or persistence of symptoms.
Results: The mixture of NBCA and iodized oil was technically successful as sclerosing therapy for managing symptomatic simple renal cysts. During median follow up period of 6 months (range 3 to 12), complete disappearance was detected in 27/41 (65.9%), reduced diameter and dis-appearance of symptoms in 11/41 (26.8) and failed procedure (due to recurrence) was detected in 3/41 (7.3%). In all the cases with failure, the pre-procedure cyst diameter was ≥10 cm. After sclerotherapy, fever (
Staff Members - Benha University